Trial intelligence / Profile preview

Remimazolam vs Propofol for hemodynamics and cerebral oxygen saturation in beach chair shoulder surgery

ChiCTR2500106453Phase 4Not yet recruiting

Sponsor
Renji Hospital
Start
Jul 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial comparing Propofol group with Remimazolam group (2 arms). Primary endpoint: Incidence of hypotension during induction and maintenance of anesthesia. Planned start Jul 2025; status: not yet recruiting.

02

Drugs

remimazolampropofol

Beyond the preview

Go deeper on ChiCTR2500106453.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500106453.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call